Structural characterization of the lipid a component of Helicobacter pylori rough- and smooth-form lipopolysaccharides

被引:157
作者
Moran, AP [1 ]
Lindner, B [1 ]
Walsh, EJ [1 ]
机构
[1] FORSCHUNGSZENTRUM BORSTEL, ZENTRUM MED & BIOWISSENSCH, D-23845 BORSTEL, GERMANY
关键词
D O I
10.1128/jb.179.20.6453-6463.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The chemical structure of free lipid A isolated from rough-and smooth-form lipopolysaccharides (R-LPS and S-LPS, respectively) of the human gastroduodenal pathogen Helicobacter pylori was elucidated by compositional and degradative analysis, nuclear magnetic resonance spectroscopy, and mass spectrometry. The predominant molecular species in both lipid A components are identical and tetraacylated, but a second molecular species which is hexaacylated is also present in lipid A from S-LPS. Despite differences in substitution by acyl chains, the hydrophilic backbone of the molecules consisted of beta(1,6)-linked D-glucosamine (GlcN) disaccharide 1-phosphate. Because of microheterogeneity, nonstoichiometric amounts of ethanolamine-phosphate were also linked to the glycosidic hydroxyl group. In S-LPS, but not in R-LPS, the hydroxyl group at position 4' was partially substituted by another phosphate group. Considerable variation in the distribution of fatty acids on the lipid A backbone was revealed by laser desorption mass spectrometry. In tetraacyl lipid A, the amino group of the reducing GlcN carried (R)-3-hydroxyoctadecanoic acid (position 2), that of the nonreducing GlcN carried (R)-3-(octadecanoyloxy)octadecanoic acid (position 2'), and ester-bound (R)-3-hydroxyhexadecanoic acid was attached at position 3. Hexaacyl lipid A had a similar substitution by fatty acids, but in addition, ester-bound (R)-3-(dodecanoyloxy)hexadecanoic acid or (R)-3(tetradecanoyloxy)hexadecanoic acid was attached at position 3'. The predominant absence of ester-bound 4'-phosphate and the presence of tetraacyl lipid A with fatty acids of 16 to 18 carbons in length differentiate H. pylori lipid A from that of other bacterial species and help explain the low endotoxic end biological activities of H. pylori LPS.
引用
收藏
页码:6453 / 6463
页数:11
相关论文
共 64 条
[1]   Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): Structure of the O antigen chain and core oligosaccharide regions [J].
Aspinall, GO ;
Monteiro, MA ;
Pang, H ;
Walsh, EJ ;
Moran, AP .
BIOCHEMISTRY, 1996, 35 (07) :2489-2497
[2]   Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: Structures of the O antigen and core oligosaccharide regions [J].
Aspinall, GO ;
Monteiro, MA .
BIOCHEMISTRY, 1996, 35 (07) :2498-2504
[3]   MOLECULAR-STRUCTURES THAT INFLUENCE THE IMMUNOMODULATORY PROPERTIES OF THE LIPID-A AND INNER-CORE REGION OLIGOSACCHARIDES OF BACTERIAL LIPOPOLYSACCHARIDES [J].
BAKER, PJ ;
HRABA, T ;
TAYLOR, CE ;
STASHAK, PW ;
FAUNTLEROY, MB ;
ZAHRINGER, U ;
TAKAYAMA, K ;
SIEVERT, TR ;
HRONOWSKI, XP ;
COTTER, RJ ;
PEREZPEREZ, G .
INFECTION AND IMMUNITY, 1994, 62 (06) :2257-2269
[4]   IMMUNOLOGICAL ACTIVITY OF LIPOPOLYSACCHARIDE OF HELICOBACTER-PYLORI ON HUMAN PERIPHERAL MONONUCLEAR BLOOD-CELLS IN COMPARISON TO LIPOPOLYSACCHARIDES OF OTHER INTESTINAL BACTERIA [J].
BIRKHOLZ, S ;
KNIPP, U ;
NIETZKI, C ;
ADAMEK, RJ ;
OPFERKUCH, W .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1993, 6 (04) :317-324
[5]  
Blaser M J, 1993, Trends Microbiol, V1, P255, DOI 10.1016/0966-842X(93)90047-U
[6]   DETERGENT-ACCELERATED HYDROLYSIS OF BACTERIAL-ENDOTOXINS AND DETERMINATION OF THE ANOMERIC CONFIGURATION OF THE GLYCOSYL PHOSPHATE PRESENT IN THE ISOLATED LIPID-A FRAGMENT OF THE BORDETELLA-PERTUSSIS ENDOTOXIN [J].
CAROFF, M ;
TACKEN, A ;
SZABO, L .
CARBOHYDRATE RESEARCH, 1988, 175 (02) :273-282
[7]   ANALYSIS OF CELL-WALL AND LIPOPOLYSACCHARIDE OF SPIRILLUM-SERPENS [J].
CHESTER, IR ;
MURRAY, RGE .
JOURNAL OF BACTERIOLOGY, 1975, 124 (03) :1168-1176
[8]   A SIMPLE AND RAPID METHOD FOR THE PERMETHYLATION OF CARBOHYDRATES [J].
CIUCANU, I ;
KEREK, F .
CARBOHYDRATE RESEARCH, 1984, 131 (02) :209-217
[9]  
Crabtree J. E., 1994, American Journal of Gastroenterology, V89, P1337
[10]  
DAVREAU RP, 1995, INFECT IMMUN, V63, P1311